CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net sales	$ 953	$ 978
Cost of products sold	447	459
Gross profit	506	519
Selling, general, and administrative expenses	415	416
Research and development expenses	42	46
Intangible asset impairments	6	0
Restructuring and other costs	1	59
Operating income (loss)	42	(2)
Other income and expenses:
Interest expense, net	18	20
Other (income) expense, net	(7)	6
Income (loss) before income taxes	31	(28)
Provision (benefit) for income taxes	14	(5)
Net income (loss)	17	(23)
Less: Net loss attributable to noncontrolling interest	(1)	(4)
Net income (loss) attributable to Dentsply Sirona	$ 18	$ (19)
Net income (loss) per common share attributable to Dentsply Sirona:
Basic (in dollars per share)	$ 0.09	$ (0.09)
Diluted (in dollars per share)	$ 0.09	$ (0.09)
Weighted average common shares outstanding:
Basic (in shares)	207.4	214.5
Diluted (in shares)	208.5	214.5